儿童门诊内镜鼻窦手术后的再入院情况
基于儿童健康信息系统2004-2016数据库的回顾性分析,纳入2011年1月至2016年12月期间接受门诊内镜鼻窦手术的18岁以下患儿3669例,30天内再入院128例(3.5%,95%CI 2.9%-4.1%)。再入院最常见指征为鼻出血(17.2%),其次为恶心/腹痛(14.1%)。多变量分析显示年龄<3岁(OR 3.41,95%CI 1.96-5.93)、既往哮喘(OR 2.88,95%CI 1.99-4.18)或囊性纤维化(OR 1.57,95%CI 1.00-2.44)显著增加再入院风险。
要点
- 儿童门诊内镜鼻窦手术后30天再入院率为3.5%(95%CI 2.9%-4.1%)。
- 再入院最常见指征为鼻出血(17.2%),其次为恶心/腹痛(14.1%)。
- 年龄<3岁、哮喘或囊性纤维化显著增加再入院风险。
核心结论
- 儿童内镜鼻窦手术是相对安全的门诊手术,总体再入院率为3.5%。
- 临床医生应考虑对非常年幼及合并囊性纤维化或哮喘的患儿进行仔细的术前评估,以优化围手术期管理并确定是否需要术后住院,因其再入院率显著更高。
研究设计与样本
- 回顾性数据库 review,使用儿童健康信息系统(PHIS)2004-2016数据库。
- 纳入2011年1月至2016年12月期间接受门诊内镜鼻窦手术且年龄<18岁的患者,分析术后30天内再入院情况。
- 收集人口学、手术范围、合并症、附加手术及费用数据,采用多变量混合效应逻辑回归模型分析。
主要发现
- 共识别3669例儿童内镜鼻窦手术病例,30天内再入院128例(3.5%;95%CI 2.9%-4.1%)。
- 再入院费用中位数为980美元(均值5890美元;标准差13421美元)。
- 再入院最常见指征为鼻出血(17.2%),其次为恶心/腹痛(14.1%);呼吸道感染(13.3%)与鼻窦炎(10.2%)合计再入院率超过鼻出血单一指征。
- 多变量分析显示年龄<3岁(OR 3.41,95%CI 1.96-5.93)、既往哮喘诊断(OR 2.88,95%CI 1.99-4.18)或囊性纤维化(OR 1.57,95%CI 1.00-2.44)显著增加再入院风险。
- 内镜鼻窦手术范围及同期腺样体切除术、鼻中隔成形术或下鼻甲减容术对再入院率无显著影响。
临床怎么用
- 作者认为,鉴于非常年幼及合并囊性纤维化或哮喘的患儿再入院率显著更高,临床医生应考虑对其进行仔细的术前评估,以优化围手术期管理并确定是否需要术后住院。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Endoscopic sinus surgery (ESS) is indicated in select pediatric patients with medically refractory sinus disease. Our objectives were to examine indications and rates of readmission following ambulatory pediatric ESS and identify specific subgroups that may benefit from inpatient admission. STUDY DESIGN: Retrospective database review. METHODS: The Pediatric Health Information Systems (PHIS) 2004-2016 database was retrospectively reviewed for patients age <18 years who underwent ambulatory ESS between January 2011 and December 2016 and were readmitted within 30 days postoperatively. Data regarding demographics, extent of surgery, comorbidities, adjunctive procedures, and cost were collected. A multivariable mixed-effects logistic regression model was employed for analysis. RESULTS: We identified 3,669 unique pediatric ESS cases with 128 readmissions within 30 days (3.5%; 95% confidence interval [CI]: 2.9%-4.1%). Median cost of readmission was $980 (mean, $5,890; standard deviation, $13,421). The most common indication for readmission was epistaxis (17.2%), followed by nausea/abdominal pain (14.1%). Respiratory infection (13.3%) and sinusitis (10.2%) presented a combined readmission rate exceeding that of epistaxis alone. Multivariable analysis indicated age <3 years (odds ratio [OR]: 3.41, 95% CI: 1.96-5.93) and a prior diagnosis of asthma (OR: 2.88, 95% CI: 1.99-4.18) or cystic fibrosis (OR: 1.57, 95% CI: 1.00-2.44) significantly increased the risk of readmission. Extent of ESS and simultaneous adenoidectomy, septoplasty, or turbinate reduction had no significant impact on readmission rates. CONCLUSIONS: ESS is a relatively safe outpatient surgical procedure in pediatric patients, with an overall readmission rate of 3.5%. Clinicians should consider careful preoperative evaluation of very young patients and those with cystic fibrosis or asthma to optimize perioperative management and determine if postoperative admission is warranted, given their significantly higher readmission rates. LEVEL OF EVIDENCE: NA Laryngoscope, 129:2681-2686, 2019.
引用
- McKeon M, Medina G, Kawai K, et al. Readmissions following ambulatory pediatric endoscopic sinus surgery. Laryngoscope. 2019. PMID: 30821352. doi:10.1002/lary.27898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。